AMBROPRO LOZENGES 20 MG (AMBROXOL HYDROCHLORIDE) – MINT FLAVOR & SUGAR-FREE ORANGE FLAVOR

Dosage form: Medicated lozenges
Active ingredient: Ambroxol Hydrochloride 20 mg per lozenge
Available variants:

• Ambropro 20 mg Lozenges – Mint Flavor.
• Ambropro 20 mg Lozenges – Sugar-Free Orange Flavor.

Therapeutic category: Throat preparations / Local analgesic and mucolytic agent.

Product Overview

Ambropro 20 mg Lozenges contain ambroxol hydrochloride, an active ingredient with local anesthetic properties that helps relieve pain and discomfort associated with acute sore throat.

The lozenges dissolve gradually in the mouth, delivering the active ingredient locally to the throat. Ambroxol helps reduce throat pain and irritation, making swallowing more comfortable.

Available in refreshing mint and sugar-free orange flavors, Ambropro provides two flavor options for convenient throat relief.

Active Ingredient and Mechanism of Action

Ambroxol Hydrochloride 20 mg

Ambroxol is a medicinal agent with local anesthetic (local pain-relieving) properties. It helps relieve sore throat discomfort through the following mechanisms:

• Local pain relief: Acts on voltage-gated sodium channels in sensory nerve fibers, reducing the transmission of pain signals from the throat.
• Relief of throat irritation: Helps alleviate painful sensations such as burning, scratchiness, and discomfort during swallowing.
• Local anti-inflammatory activity: Experimental studies suggest that ambroxol has additional anti-inflammatory properties, although these should not be interpreted as proof of a clinically significant anti-inflammatory effect from lozenges.

The lozenge formulation allows gradual dissolution in the mouth, providing local exposure to the active ingredient.

Indications and Benefits

Ambropro 20 mg Lozenges are indicated for the symptomatic relief of acute sore throat.

Potential therapeutic benefits include:

1. Relieves Acute Sore Throat: Helps reduce pain and discomfort associated with acute pharyngitis.
2. Eases Painful Swallowing: Helps make swallowing more comfortable by reducing throat pain.
3. Soothes Throat Irritation: Helps alleviate burning, scratchiness, and throat discomfort.
4. Provides Local Anesthetic Action: Helps reduce the transmission of pain signals from sensory nerves.
5. Convenient Throat Relief: Gradually dissolves in the mouth, allowing local delivery of the active ingredient.

Clinical studies have investigated ambroxol 20 mg lozenges and demonstrated pain-relieving benefits in acute uncomplicated sore throat. However, results have varied between formulations, and not every clinical trial demonstrated superiority over placebo.

Dosage and Administration

According to the Egyptian Drug Authority's 2026 National Drug Formulary:

• Adults and adolescents aged 12 years and above: One 20 mg lozenge as needed.
• Maximum daily dose: 6 lozenges (120 mg ambroxol hydrochloride).
• Maximum treatment duration: 3 days without medical advice.

Method of administration:

• Allow the lozenge to dissolve slowly in the mouth.
• Do not chew or swallow it whole.
• Do not exceed the recommended daily dose.
• Seek medical advice if symptoms persist, worsen, or are accompanied by fever.

Important: Follow the specific product leaflet if its approved dosing instructions differ.

Available Flavors

Ambroxol lozenges are generally well tolerated when used as directed. However, some adverse effects may occur:

Common or relatively frequent:

• Taste disturbances (dysgeusia).
• Nausea.
• Temporary numbness of the mouth or throat.
• Oral or pharyngeal hypoesthesia.

Rare but potentially serious:

• Allergic reactions, including skin rash, itching, and swelling.
• Severe hypersensitivity reactions, including anaphylaxis.
• Severe skin reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis.

Discontinue treatment and seek medical attention immediately if a progressive skin rash, blistering, mucosal lesions, or signs of a serious allergic reaction develop.

Warnings and Precautions

• Hypersensitivity: Avoid use in patients with known allergy to ambroxol hydrochloride or any product ingredient.
• Pregnancy and breastfeeding: Consult a healthcare professional before use, particularly during pregnancy or breastfeeding.
• Renal or hepatic impairment: Patients with significant kidney or liver dysfunction should seek medical advice before use.
• Persistent symptoms: Medical evaluation is recommended if symptoms persist beyond three days, worsen, or are accompanied by fever.
• Children: The 20 mg lozenge formulation is generally intended for adults and adolescents aged 12 years and above.
• Sugar-free formulation: Check the complete excipient list for sugar substitutes and other ingredients before recommending it to patients with specific dietary restrictions.

Contraindications

• Known hypersensitivity to ambroxol hydrochloride.
• Known hypersensitivity to any of the formulation's excipients.

Drug Interactions

No major clinically significant interactions are specifically established for ambroxol lozenges. However, patients should inform their healthcare professional about all medicines they are taking, particularly other throat preparations or medications intended to relieve similar symptoms.

Storage Conditions

• Store in a cool, dry place.
• Protect from direct sunlight and moisture.
• Keep out of reach of children.
• Follow the storage conditions printed on the original packaging.

References

1. Egyptian Drug Authority (EDA). Egyptian National Drug Formulary – Respiratory Medicines, 2026. Ambroxol: indications, dosage, contraindications, and adverse effects.
2. National Library of Medicine (PubMed). Fischer J, et al. Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat. Randomised, double-blind, placebo-controlled trials. Read clinical study.
3. BMC Family Practice (2014). Efficacy of ambroxol lozenges for pharyngitis: a meta-analysis. Read systematic review.
4. European Medicines Agency (EMA). Ambroxol and bromhexine expectorants: updated safety information concerning hypersensitivity and severe skin reactions. EMA safety information.
5. French National Agency for Medicines and Health Products Safety (ANSM). Summary of Product Characteristics – Ambroxol 20 mg lozenges, including indications, dosage, and precautions. Official product information.
6. Pulmonary Therapy (2019). Randomized, double-blind, placebo-controlled study assessing the efficacy and safety of ambroxol 20 mg lozenges in acute pharyngitis. Read clinical trial.
7. European Commission. Ambroxol/bromhexine safety review and recommendations regarding severe cutaneous adverse reactions. Regulatory safety document.

Patient Disclaimer

This product description is intended for educational and informational purposes only. Ambropro 20 mg Lozenges are intended for the symptomatic relief of acute sore throat and are not a substitute for professional medical diagnosis or treatment. They do not treat the underlying cause of every throat infection and should not replace antibiotics when these are clinically indicated. Always follow the package instructions and consult a qualified healthcare professional before use, particularly during pregnancy, breastfeeding, or in patients with underlying medical conditions. This product is not intended to diagnose, treat, cure, or prevent any disease.